FATE THERAPEUTICS INC (FATE) Stock Income Statement
USA - NASDAQ:FATE - US31189P1021 - Common Stock
0.964 USD
-0.03 (-2.85%)
0.9801 USD
+0.02 (+1.67%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.47M | 13.63M | 63.53M | 96.30M | 55.85M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 186.11M | 209.17M | 254.04M | 404.69M | 272.84M | |||
| Research and Development | 124.83M | 135.00M | 172.60M | 320.45M | 215.52M | |||
| Selling, General, and Administrative Expenses | 61.28M | 74.17M | 81.45M | 84.23M | 57.32M | |||
| Operating Income | -177.64M | -195.54M | -190.51M | -308.39M | -216.99M | |||
| Interest Income/Expense | 15.43M | 18.11M | 19.70M | 26.15M | 4.84M | |||
| Other Income/Expense | 5.42M | 5.91M | 9.88M | 520.00K | null | |||
| Non Recurring Items | null | -14.74M | null | null | null | |||
| Income Before Taxes | -171.52M | -186.26M | -160.93M | -281.72M | -212.15M | |||
| Income Tax | null | null | null | null | null | |||
| Net Income | -171.52M | -186.26M | -160.93M | -281.72M | -212.15M | |||
| EBITDA | -161.60M | -176.58M | -172.23M | -294.63M | -211.14M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.4526000000000001 | -1.6384 | -1.6353 | -2.91 | -2.24 | |||
| Non GAAP EPS | -1.4500000000000002 | -1.6400000000000001 | -1.6400000000000001 | -2.91 | -2.23 | |||
| Statistics | ||||||||
| Profit Margin | -2025.05% | -1366.46% | -253.30% | -292.54% | -379.86% | |||
| Operating Profit Margin | -2097.24% | -1434.52% | -299.86% | -320.24% | -388.52% | |||
All data in USD